NASDAQ: SLN
Silence Therapeutics PLC Stock Ownership - Who owns Silence Therapeutics?

Insider buying vs selling

Have Silence Therapeutics PLC insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when SLN insiders and whales buy or sell their stock.

SLN Shareholders

What type of owners hold Silence Therapeutics PLC stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Tcg Crossover Management LLC2.14%3,033,560$18.50MInstitution
Siren LLC2.05%2,911,438$17.76MInstitution
Redmile Group LLC1.53%2,164,777$13.21MInstitution
Nantahala Capital Management LLC1.51%2,146,731$13.10MInstitution
Citadel Advisors LLC0.87%1,234,807$7.53MInstitution
Millennium Management LLC0.76%1,074,191$6.55MInstitution
Great Point Partners LLC0.72%1,020,489$6.22MInstitution
Nextech Invest Ltd0.67%952,400$5.81MInstitution
Ikarian Capital LLC0.61%865,784$5.28MInstitution
Tetragon Partners GP Ltd0.44%630,161$3.84MInstitution

1 of 3

SLN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SLN13.91%0.09%
ZNTL57.71%42.29%Net Selling
TARA57.72%42.28%Net SellingNet Selling
NAGE20.57%79.43%Net BuyingNet Buying
AKBA36.87%8.14%Net SellingNet Buying

Silence Therapeutics Stock Ownership FAQ

Who owns Silence Therapeutics?

Silence Therapeutics (NASDAQ: SLN) is owned by 13.91% institutional shareholders, 0.09% Silence Therapeutics insiders, and 86.01% retail investors. Tcg Crossover Management LLC is the largest individual Silence Therapeutics shareholder, owning 3.03M shares representing 2.14% of the company. Tcg Crossover Management LLC's Silence Therapeutics shares are currently valued at $18.50M.

If you're new to stock investing, here's how to buy Silence Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.